Cleared Traditional

K100720 - K-SHIELD PORT ACCESS INFUSION SET WITH HIGH PRESSURE TUBING

K100720 is an FDA 510(k) clearance for K-SHIELD PORT ACCESS INFUSION SET WITH ..., manufactured by Kawasumi Laboratories, Inc.. The device is a Class 2 General Hospital device with product code FPA cleared through the Traditional 510(k) pathway after a 248-day FDA review.

K100720 · Kawasumi Laboratories, Inc. · General Hospital
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 2010
Decision
248d
Days
Class 2
Risk

K100720 is an FDA 510(k) clearance for the K-SHIELD PORT ACCESS INFUSION SET WITH HIGH PRESSURE TUBING. Classified as Set, Administration, Intravascular (product code FPA), Class II - Special Controls.

Submitted by Kawasumi Laboratories, Inc. (Washington, US). The FDA issued a Cleared decision on November 18, 2010 after a review of 248 days - an extended review cycle.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5440 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the General Hospital review framework, consistent with the majority of Class II 510(k) submissions.

View all Kawasumi Laboratories, Inc. devices

FDA 510(k) Submission Details - K100720

510(k) Number K100720 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 15, 2010
Decision Date November 18, 2010
Days to Decision 248 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
119d slower than avg
Panel avg: 129d · This submission: 248d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

FPA Device Classification - Class 2, Special Controls

Product Code FPA Set, Administration, Intravascular
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5440
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - FPA Set, Administration, Intravascular

All 771
Devices cleared under the same product code (FPA) and FDA review panel - the closest regulatory comparables to K100720.
HOSPIRA PLUM INFUSION SET
K103224 · Hospira, Inc. · Jan 2011
HIGH PRESSURE SETS-400 PSI
K100576 · Icu Medical, Inc. · Dec 2010
INFUSION SETS
K103344 · Hospira, Inc. · Dec 2010
BLOOD SAMPLING SET
K103165 · Acacia, Inc. · Nov 2010
AMSINO I.V. ADMINISTRATION AND EXTENSION SETS
K101958 · Amsino International, Inc. · Sep 2010
ACCU-CHEK ULTRFLEX INFUSION SET
K101196 · Roche Diagnostics Corp. · Aug 2010